| 查看: 1334 | 回复: 4 | |||
[交流]
抗体部门高级科学家
|
|
Responsibilities: 1. Lead a dynamic group of scientists to work on antibody discovery projects for major pharmaceuticals, biotech and academia customers 2. Manage project progress and trouble-shooting, provide project updates to internal and external customers, and etc. 3. Customize project plans based on customer’s requests on antibody lead generation, optimization and characterization 4. Improve core competency in the field of antibody generation and engineering 5. Participate in strategy development on business, production and innovation 6. Communicate with the commercial teams to provide new service proposals and promotions; investigate key technologies and platforms to boost the service performance; Qualifications: 1. Ph. D. with two years or Master degree with five years’ experience in immunology, drug discovery, pharmaceutical science or a related field with expertise on hybridoma generation, single B cell technology, phage display, antibody humanization, and affinity maturation; 2. A thorough understanding and hand-on experience in industry setting of therapeutic antibody lead generation, optimization and characterization of antibody drugs; 3. Playing a key role in scientific leadership, including study design, literature reference research, project direction, and scientific discussion; 4. Multitasking, self-motivating, innovative, and result and detail-oriented; 5. Proactively participating in collaborative projects; 6. Bilingual in English and Chinese, with strong communication skills. [ 来自版块群 江苏 ] |
» 猜你喜欢
售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急
已经有3人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有3人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有5人回复
售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急
已经有7人回复
上海工程技术大学 激光智能制造课题组 2027级博士研究生招生
已经有6人回复
课题组招2027级博士 上海工程技术大学 激光智能制造方向
已经有6人回复
现代”学阀”该如何界定
已经有14人回复
师弟论文见刊大半年才想起来申请专利,还能抢救一下吗?
已经有4人回复
|
2楼2017-11-27 18:02:48
3楼2017-11-29 11:11:35
4楼2017-12-11 08:51:08
5楼2018-01-08 12:14:17










回复此楼